Here is a selection of our most common queries.
How do you get such consistently high results?
The key to our results is individualised treatment. We are a relatively small team who have worked together for many years and do our utmost to provide a friendly and personal service. On the clinical side, every couple is seen by an experienced specialist doctor and treatment is overseen at every stage by Mr Taranissi (Medical Director), an experienced reproductive medicine expert.
How can I make an appointment?
It’s simple – you register for an appointment by filling in our registration form (see appointments). You will need to send us any existing results or records from previous infertility treatment, any locally-organised blood test results and a £50 deposit, which will be refunded against your consultation fee.
If you cannot access the form online, call our dedicated ‘New Patient’ line on 0207 486 1779 and we will send it to you.
What happens at the first consultation?
The initial consultation lasts up to an hour, during which time the woman and her partner may be examined. The first consultation allows you to fully discuss your history, treatment options and any other relevant material.
How long does treatment take?
As a guide, treatment can take approximately four to six weeks, however this entirely depends on each individual. Some patients may be required to undergo extra testing and monitoring before they start treatment.
Generally, patients are down-regulated using a nasal spray or an injection for around two weeks before beginning an eight to twelve day course of hormone injections. Two days after the human chorionic gonadotrophin (HCG) trigger injection, the woman will have her egg collection performed under sedation. Two to five days after that, the embryo transfer will take place. A pregnancy test is then performed ten to twelve days later.
Do I need to take time off work for treatment?
This will depend on your individual circumstances. Monitoring during the ovarian stimulation phase can be very intensive and you may need to have blood tests and scans on a daily, or sometimes twice-daily basis. This level of monitoring can last up to two weeks. Time off may not be necessary if you are able to work flexibly, or if your employers are sympathetic. If you are not in any of these situations you may find treatment less stressful if you arrange some time off work. If you are interested in taking up our Tring or Oxford options, please let us know.
After the embryo transfer, we recommend that you take as much time as possible off work while waiting for your pregnancy test.
Will I be seen by the same doctor at each visit?
We have a dedicated team of clinicians and you may be seen by any one of them throughout your treatment cycle. It is not always possible for you to see the same doctor each time you visit. Our team works very closely together and your treatment will always be overseen by the senior consultant on a daily basis.
What will happen if my treatment is not successful?
A follow-up consultation is provided for all patients whose treatment is unsuccessful. This consultation gives you the opportunity to fully discuss your treatment cycle and options for the future with one of our clinicians. This follow up consultation is free of charge.
What do the following terms mean?
|adhesions||Bands of scar tissue attached to organ surfaces and capable of connecting, covering, or distorting organs, such as tubes, ovaries or uterus. Can also occur inside uterine cavity; increased risk with history of multiple miscarriages, D&C’s and C-sections.|
|AID (artificial insemination, donor)||A procedure introducing sperm from an anonymous donor into a woman’s uterus in order to achieve a pregnancy.|
|AIH (artificial insemination, husband or homologous)||A special insemination procedure used to introduce sperm collected from a woman’s partner into the woman’s uterus. Also referred to as intrauterine insemination (IUI).|
|antisperm antibodies||Antibodies that may be produced by either a female or male which may damage sperm or cause them to adhere to each other, thus limiting their fertility potential.|
|azoospermia||The absence of sperm in the ejaculate.|
|cervical mucus||Mucus produced by the cervix which changes in thickness and quantity at the time of ovulation.|
|cervix||The lower section of the uterus which protrudes into the vagina and serves as a passageway for sperm into the uterus.|
|corpus luteum||The remainder of the follicle in the ovary that develops after the egg is released, which secretes progesterone.|
|cryopreservation||The preservation of sperm, embryos or eggs by freezing, usually by immersion in liquid nitrogen.|
|endometriosis||The presence of endometrial tissue in abnormal locations, such as the fallopian tubes, ovaries and abdominal cavity. The condition frequently causes pain and discomfort during menstruation, or intercourse, or even chronic pelvic pain. May also cause infertility.|
|endometrium||The inner lining of the uterus.|
|estrogen||The primary female hormone produced mainly by the ovaries from puberty to menopause.|
|fallopian tube||The tube that connects the uterus and ovary. It allows the egg to pass from the ovary to the uterus and the spermatozoa from the uterus toward the ovary.|
|fibroids||Also known as leiomyoma, Pl Leiomyomata. Smooth muscle tumours of the muscular wall of the uterus which are almost always benign but may cause infertility or recurrent miscarriages, or gynecologic symptoms such as painful/heavy menses, pelvic “heaviness” or pain|
|follicle||A cystic structure in the ovary which contains and nurtures the ovum (egg). It enlarges to a diameter of 18 – 28 mm (3/4 – 1 inch) before ovulation, at which point it releases the egg.|
|Fostimon||The brand name of a new recombinant FSH used to stimulate the ovaries to produce follicles.|
|FSH (follicle stimulating hormone)||A hormone that recruits and then stimulates growth of the follicle in the ovary, as well as the formation of spermatozoa in the testes.|
|Cetrotide||A GnRH antagonist that can be used to prevent premature ovulation in IVF cycles.|
|gonadotropin||A hormone (FSH, LH, hMG, hCG) which stimulates the gonads (ovaries or testes).|
|GnRH (gonadotropin releasing hormone)||A small hormone produced by the brain which causes the pituitary gland to manufacture and release FSH and LH.|
|GnRH agonist (Lupron)||Differs from GnRH at 2 amino-acid positions. Used to stop production of FSH and LH from the pituitary gland. Can also be used to trigger ovulation in specially designed protocols.Also used to treat endometriosis and fibroids.|
|hCG (human chorionic gonadotropin)||A hormone produced by the placenta. Detection of its presence in urine or blood is the basis of the pregnancy test. Also used to trigger final maturation and ovulation of the egg.|
|hMG (human menopausal gonadotropin)||A hormone (Merional) used to stimulate follicle production. Equal parts of FSH and LH activity are present.|
|hysteroscopy||An endoscopic (fiber-optic tube) procedure used primarily to visualise the interior of the uterus.|
|implantation||The embedding of the embryo in the uterine wall.|
|in-vitro fertilization/embryo transfer||A procedure in which an egg is removed from a ripe follicle and fertilised with sperm outside the body. The resulting embryo is inserted into the woman’s uterus.|
|laparoscopy||An abdominal surgical procedure using an endoscopic instrument (fiber-optic tube) to view the fallopian tubes, ovaries, uterus, and other abdominal structures. The laparoscope may also be used to perform surgical procedures, employing the use of lasers and other specialised equipment.|
|LH (luteinizing hormone)||A hormone produced and released by the pituitary gland. In the female, it is responsible for maturation and then the release of the ovum. In the male, it stimulates testosterone production.|
|oligospermia||The presence of a low number of sperm in the ejaculate.|
|ovum||The egg cell (gamete) produced in a woman’s ovaries during each menstrual cycle.|
|ovulation||The release of a mature egg from the surface of the ovary.|
|PGD||Preimplantation Genetic Diagnosis|
|pituitary gland||A gland at the base of the brain which produces many hormones, including FSH and LH.|
|polyps||Small, mostly benign, growths protruding from the lining of the endometrium or endocervix. More common in patients with irregular menses or PCOS|
|progesterone||A hormone produced and released during the second half of a woman’s ovulatory cycle. It is necessary in the preparation of the uterine lining for implantation of the fertilised egg.|
|semen||The sperm and seminal secretions ejaculated by the male during orgasm.|
|sperm||Male reproductive cells contained in the seminal fluid.|
|Suction morcellator||Newest hysteroscopic technology to remove intrauterine polyps, fibroids, and adhesions. Allows more complete removal of larger, more technically demanding fibroids than was previously possible.|
|testosterone||The most potent male sex hormone, produced in the testes.|
|uterus||The reproductive organ which protects and nourishes the developing embryo/foetus. It is a hollow, muscular structure that is part of the female reproductive tract, and it is the source of a woman’s menses.|
|vagina||A tubular passageway in the female which connects the external sex organs with the cervix and uterus.|